• Home
  • BLIS Technologies Ltd

BLIS Technologies Ltd

  • PROBIOTICS MADE TO MATTER
  • BLIS TECHNOLOGIES
  • MASTERS OF THE ORAL MICROBIOME
About BLIS Technologies Ltd

PROBIOTIC PIONEERS FOR A HEALTHIER YOU

BLIS Technologies Limited was founded on the ground-breaking research of Professor John Tagg (University of Otago, New Zealand) and the discovery of the oral probiotic strains BLIS K12™ and BLIS M18™. Our strains are backed by over 30 years of robust research, over 70 clinical trials and an IP-protected supply chain. We offer partners both ingredient and finished products within broad health areas, including immunity, teeth & gums, mouth, throat and oral health.

Read more Show less
Certifications
  • FDA
    FDA
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    New Zealand
  • On CPHI since:
    2024
  • Certificates:
    2
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contact info
  • Website
  • 10, Birch St,Dunedin,PO Box No 2208,, 9059, Dunedin, New Zealand
Show contact info Hide contact info
Meet us at

CPHI Korea 2026

COEX, Seoul, Korea
25 Aug 2026 - 27 Aug 2026
View Exhibitor Profile

Products from BLIS Technologies Ltd (2)

  • BLIS K12™ (Streptococcus salivarius K12)

    Product BLIS K12™ (Streptococcus salivarius K12)

    BLIS K12™ (Streptococcus salivarius K12) is an oral probiotic to support mouth and throat. It originates from the oral microbiome and targets multiple concerns, including ENT (ears, nose and throat) health, immunity and bad breath. • Helps maintain a healthy oral microbiome • Supports ear, nose, and ...
  • BLIS M18™ (Streptococcus salivarius M18)

    Product BLIS M18™ (Streptococcus salivarius M18)

    BLIS M18™ (Streptococcus salivarius M18) is an oral probiotic to support teeth and gum health. It originates from the oral microbiome and is proven to maximise good dental hygiene, for the support of teeth, gums and overall health.

BLIS Technologies Ltd Resources (3)

  • BLIS Technologies Enters the Pet Health Category with Clinically-Studied Oral Probiotics for Dogs

    News BLIS Technologies Enters the Pet Health Category with Clinically-Studied Oral Probiotics for Dogs

    BLIS K12™ and BLIS M18™ — the world's first commercialised oral probiotic strains — extend their 25-year human health heritage into companion animal care, addressing one of the most prevalent yet under-treated conditions in dogs.

    5 May 2026
  • PROBIOTICS MADE TO MATTER | BLIS TECHNOLOGIES

    Video PROBIOTICS MADE TO MATTER | BLIS TECHNOLOGIES

    BLIS Technologies are the masters of the oral microbiome. We are dedicated to discovering, developing, and supplying clinically validated probiotic strains that support oral and upper respiratory health. We were the first to discover Streptococcus salivarius probiotics — BLIS K12™ and BLIS M18™ — and we’ve been leading the science of the oral cavity ever since. BLIS K12™ and BLIS M18™ are backed by decades of research, strong IP, and extensive clinical validation.
    2026-05-05
  • ORAL HEALTH BY BLIS

    Brochure ORAL HEALTH BY BLIS

    The category case for oral probiotics, the oral-systemic health story, full strain profiles for BLIS M18™ (dental, gum, plaque) and BLIS K12™ (ENT, throat, fresh breath), a curated selection of clinical evidence for each strain, and information on application areas and what BLIS provides to formulators.